Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Progresses During or After Prior Systemic Anti-angiogenic Regimen
Clinical trial NCT03013335 · COMPLETED
Trial details
- NCT number
- NCT03013335
- Sponsor
- UNICANCER
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2018-06-01
- Enrollment
- 730
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.